Correlation Between Aquestive Therapeutics and Forward Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Aquestive Therapeutics and Forward Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aquestive Therapeutics and Forward Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Aquestive Therapeutics and Forward Pharma A, you can compare the effects of market volatilities on Aquestive Therapeutics and Forward Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aquestive Therapeutics with a short position of Forward Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aquestive Therapeutics and Forward Pharma.

Diversification Opportunities for Aquestive Therapeutics and Forward Pharma

0.07
  Correlation Coefficient

Significant diversification

The 3 months correlation between Aquestive and Forward is 0.07. Overlapping area represents the amount of risk that can be diversified away by holding Aquestive Therapeutics and Forward Pharma A in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Forward Pharma A and Aquestive Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aquestive Therapeutics are associated (or correlated) with Forward Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Forward Pharma A has no effect on the direction of Aquestive Therapeutics i.e., Aquestive Therapeutics and Forward Pharma go up and down completely randomly.

Pair Corralation between Aquestive Therapeutics and Forward Pharma

If you would invest  295.00  in Aquestive Therapeutics on September 2, 2024 and sell it today you would earn a total of  214.00  from holding Aquestive Therapeutics or generate 72.54% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy0.79%
ValuesDaily Returns

Aquestive Therapeutics  vs.  Forward Pharma A

 Performance 
       Timeline  
Aquestive Therapeutics 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Aquestive Therapeutics are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively conflicting basic indicators, Aquestive Therapeutics unveiled solid returns over the last few months and may actually be approaching a breakup point.
Forward Pharma A 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Forward Pharma A has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable basic indicators, Forward Pharma is not utilizing all of its potentials. The current stock price agitation, may contribute to short-term losses for the retail investors.

Aquestive Therapeutics and Forward Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Aquestive Therapeutics and Forward Pharma

The main advantage of trading using opposite Aquestive Therapeutics and Forward Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aquestive Therapeutics position performs unexpectedly, Forward Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Forward Pharma will offset losses from the drop in Forward Pharma's long position.
The idea behind Aquestive Therapeutics and Forward Pharma A pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.

Other Complementary Tools

Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity